Regulatory T cell-derived IL-10 ameliorates crescentic GN

Journal of the American Society of Nephrology

Volumn 24, Issue 6, 2013, Pages 930-942

  Ostmann, Annett ^a   Paust, Hans Joachim ^a   Panzer, Ulf ^a   Wegscheid, Claudia ^a   Kapffer, Sonja ^a   Huber, Samuel ^a   Flavell, Richard A ^b   Erhardt, Annette ^a   Tiegs, Gisa ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRESCENTIC GLOMERULONEPHRITIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; GLOMERULONEPHRITIS; KIDNEY INJURY; KIDNEY PARENCHYMA; LYMPHOCYTE FUNCTION; LYMPHOID TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL;

EID: 84878709846     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012070684     Document Type: Article

References (41)

1. Sakaguchi S, Sakaguchi N, AsanoM, ItohM, TodaM: Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alpha- chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164, 1995
2. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T: Regulatory T cells: How do they suppress immune responses? Int Immunol 21: 1105-1111, 2009
3. Vignali DA, Collison LW,Workman CJ: How regulatory T cells work. Nat Rev Immunol 8: 523-532, 2008
4. Paust S, Cantor H: Regulatory T cells and autoimmune disease. Immunol Rev 204: 195-207, 2005
5. Costantino CM, Baecher-Allan C, Hafler DA: Multiple sclerosis and regulatory T cells. J Clin Immunol 28: 697-706, 2008
6. Notley CA, Ehrenstein MR: The yin and yang of regulatory T cells and inflammation in RA. Nat Rev Rheumatol 6: 572-577, 2010
7. Bettini M, Vignali DA: Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 21: 612-618, 2009
8. Wolf D, Hochegger K,Wolf AM, Rumpold HF, Gastl G, Tilg H,Mayer G, Gunsilius E, Rosenkranz AR: CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J AmSoc Nephrol 16: 1360-1370, 2005
9. Turner JE, Paust HJ, Steinmetz OM, Peters A, Riedel JH, Erhardt A, Wegscheid C, Velden J, Fehr S, Mittrücker HW, Tiegs G, Stahl RA, Panzer U: CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J AmSoc Nephrol 21: 974-985, 2010
10. Eller K, Weber T, Pruenster M, Wolf AM, Mayer G, Rosenkranz AR, Rot A: CCR7 deficiency exacerbates injury in acute nephritis due to aberrant localization of regulatory T cells. J Am Soc Nephrol 21: 42-52, 2010
11. Paust HJ, Ostmann A, Erhardt A, Turner JE, Velden J, Mittrücker HW, Sparwasser T, Panzer U, Tiegs G: Regulatory T cells control the Th1 immune response in murine crescentic glomerulonephritis. Kidney Int 80: 154-164, 2011
12. Ooi JD, Snelgrove SL, Engel DR, Hochheiser K, Ludwig-Portugall I, Nozaki Y, O'Sullivan KM, Hickey MJ, Holdsworth SR, Kurts C, Kitching AR: Endogenous foxp3(+) T-regulatory cells suppress anti-glomerular basement membrane nephritis. Kidney Int 79: 977-986, 2011
13. Shevach EM: Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645, 2009
14. Kitching AR, Tipping PG, Timoshanko JR, Holdsworth SR: Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis. Kidney Int 57: 518-525, 2000
15. Rubtsov YP, Rasmussen JP,Chi EY, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, Henderson WR Jr, Muller W, Rudensky AY: Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28: 546-558, 2008
16. KamanakaM, Kim ST,Wan YY, Sutterwala FS, Lara-TejeroM, Galán JE, Harhaj E, Flavell RA: Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25: 941-952, 2006
17. Mitsdoerffer M, Lee Y, Jäger A, Kim HJ, Korn T, Kolls JK, Cantor H, Bettelli E, Kuchroo VK: Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A 107: 14292-14297, 2010
18. Yamaguchi T, Wing JB, Sakaguchi S: Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions. Semin Immunol 23: 424-430, 2011
19. Eller K,Wolf D, Huber JM, Metz M, Mayer G, McKenzie AN, Maurer M, Rosenkranz AR, Wolf AM: IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression. J Immunol 186: 83-91, 2011
20. Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, Ye H, Ju ST, Okusa MD: Regulatory T cells suppress innate immunity in kidney ischemiareperfusion injury. J Am Soc Nephrol 20: 1744-1753, 2009
21. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F: An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190: 995-1004, 1999
22. Uhlig HH, Coombes J, Mottet C, Izcue A, Thompson C, Fanger A, Tannapfel A, Fontenot JD, Ramsdell F, Powrie F: Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol 177: 5852-5860, 2006
23. Annacker O, Asseman C, Read S, Powrie F: Interleukin-10 in the regulation of T cell-induced colitis. J Autoimmun 20: 277-279, 2003
24. Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H, Kronenberg M: Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 10: 1178-1184, 2009
25. Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich JM, Jack RS, Wunderlich FT, Brüning JC, Müller W, Rudensky AY: Interleukin- 10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34: 566-578, 2011
26. Gravano DM, Vignali DA: The battle against immunopathology: Infectious tolerance mediated by regulatory T cells. Cell Mol Life Sci 69: 1997-2008, 2012
27. Huber S, Gagliani N, Esplugues E,O'ConnorWJr, Huber FJ, Chaudhry A, Kamanaka M, Kobayashi Y, Booth CJ, Rudensky AY, Roncarolo MG, Battaglia M, Flavell RA: Th17 cells express interleukin-10 receptor and are controlled by Foxp3- and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 34: 554-565, 2011
28. Voo KS,Wang YH, Santori FR, Boggiano C, Wang YH, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, Littman DR, Liu YJ: Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A 106: 4793-4798, 2009
29. Lochner M, Peduto L, Cherrier M, Sawa S, Langa F, Varona R, Riethmacher D, Si-Tahar M, Di Santo JP, Eberl G: In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J ExpMed 205: 1381-1393, 2008
30. Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, Cua DJ, Ahlfors H, Wilhelm C, Tolaini M, Menzel U, Garefalaki A, Potocnik AJ, Stockinger B: Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 12: 255-263, 2011
31. Carter NA, Rosser EC, Mauri C: Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis. Arthritis Res Ther 14: R32, 2012
32. RodriguezW,Mold C, KataranovskiM, Hutt JA,Marnell LL, Verbeek JS, Du Clos TW: C-reactive protein-mediated suppression of nephrotoxic nephritis: role of macrophages, complement, and Fcgamma receptors. J Immunol 178: 530-538, 2007
33. Wilson HM, Stewart KN, Brown PA, Anegon I, Chettibi S, Rees AJ, Kluth DC: Bone-marrow-derived macrophages genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis. Mol Ther 6: 710-717, 2002
34. Tadagavadi RK, Reeves WB: Endogenous IL-10 attenuates cisplatin nephrotoxicity: Role of dendritic cells. J Immunol 185: 4904-4911, 2010
35. CopeA, Le FriecG,Cardone J,Kemper C: TheTh1 life cycle:Molecular control of IFN-g to IL-10 switching. Trends Immunol 32: 278-286, 2011
36. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274, 1993
37. Siewe L, Bollati-FogolinM,Wickenhauser C, Krieg T,Müller W, Roers A: Interleukin-10 derived frommacrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA. Eur J Immunol 36: 3248-3255, 2006
38. Paust HJ, Turner JE, Riedel JH, Disteldorf E, Peters A, Schmidt T, Krebs C, Velden J, Mittrücker HW, Steinmetz OM, Stahl RA, Panzer U: Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis. Kidney Int 82: 72-83, 2012
39. Turner JE, Paust HJ, Steinmetz OM, Peters A, Meyer-Schwesinger C, Heymann F, Helmchen U, Fehr S, Horuk R, Wenzel U, Kurts C, Mittrücker HW, Stahl RA, Panzer U: CCR5 deficiency aggravates crescentic glomerulonephritis in mice. J Immunol 181: 6546-6556, 2008
40. Paust HJ, Turner JE, Steinmetz OM, Peters A, Heymann F, Hölscher C, Wolf G, Kurts C,Mittrücker HW, Stahl RA, Panzer U: The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. J Am Soc Nephrol 20: 969-979, 2009
41. Riedel JH, Paust HJ, Turner JE, Tittel AP, Krebs C, Disteldorf E, Wegscheid C, Tiegs G, Velden J, Mittrücker HW, Garbi N, Stahl RA, Steinmetz OM, Kurts C, Panzer U: Immature renal dendritic cells recruit regulatory CXCR6(+) invariant natural killer T cells to attenuate crescentic GN. J Am Soc Nephrol 23: 1987-2000, 2012